CTLA4 and type 1 diabetes mellitus: Median time to ICI-induced IDDM presentation in patients treated with other combinations was 2 months (95% CI 0.2–3.8) and was not significantly different from patients treated with monotherapy (p = 0.58) and from patients treated with anti-CTLA4 combinations (p = 0.38).